期刊文献+

微血管密度、抑血管内皮生长因子及其受体表达与乳腺癌临床病理因素的关系

The relationship between the expression of vascular endothelial growth factor and it's acceptor and microvessel density with the clinicopathological features of breast carcinoma
原文传递
导出
摘要 目的评价微血管密度(MVD)和抑血管内皮生长因子(VEGF)及其受体(Flk-1)在乳腺癌组织中的表达对预后的判断价值。方法用免疫组织化学染色方法检测76例乳腺癌、10例癌旁正常乳腺组织中抑血管内皮生长因子和受体的表达,并在CD34染色切片上检测微血管密度。结果(1)癌组织VEGF和Flk-1阳性表达率分别为59.2%和61.8%,明显高于癌旁组织(P<0.05);(2)乳腺癌MVD均值为(30.49±16.51)个/200倍视野,明显高于癌旁正常组织(P<0.01);(3)乳腺癌MVD与肿瘤大小、组织学分级、腋淋巴转移及复发转移有关(P<0.01);(4)血管内皮生长因子和受体的表达与腋淋巴转移及复发转移有关(P<0.05);(5)血管内皮生长因子和受体阳性组MVD均值(54.93±13.86)高于阴性组(41.28±11.69),其表达与MVD有关(P<0.01)。结论乳腺癌的VEGF和Flk-1表达阳性率与MVD大于良性乳腺疾病。VEGF和Flk-1与MVD与患者的预后相关,均可作为判断乳癌患者预后的指标之一。VEGF和Flk-1不是影响肿瘤新生血管形成的惟一因素。 Objective To study the prognosis value of the expression of vascular endothelial growth factor and it's acceptor(VEGF, Flk-1 ) and microvessel density(MVD) gene proteins in the breast carcinoma and paracarcinoma tissue. Methods Immunohistochemical technique was adopted to detect the protein expression of VEGF, Flk- 1 and MVD in 76 cases of breast carcinoma and 10 cases paracarcinorna tissue. Results ( 1 ) The positive expression of VEGF, Flk-1 were 59.3 % and 61.3 % in the carcinoma group, which were higher than in the paracarcinorna tissue(P 〈 0.05). (2)The average MVD in the breast carcinoma were (30.49 ± 16.51 )/200HF, which were higher in the paracarcinoma tissue(P 〈 0.01 ). (3)The average MVD in the breast carcinoma were associated with the size of tumour, histology grade, armpit lymph noodle metastasis and reoccurance( P 〈 0.01 ). (4)The expression of VEGF and Flk-1. were associated with thearmpit lymph noodle metastasis, and reoccurance( P 〈 0.05 ). (5)The average MVD in the positive expression of VEGFand Flk-1 group (54.93 ± 13.86) were higher( P 〈 0.01 ) than i.n the negative expression of VEGF and Flk-1 group (41028 ± 11.69). Conclusion The expressions of VEGF, Flk-1 and MVD in the breast carcinoma are higher than in the beniga paracarcinorna tissue,which is associated.with breast car, cinoma pronnosis. The VEGF, Flk-2 are not the single angiogenesis factors of inducing tumour new vessel.
出处 《中国基层医药》 CAS 2006年第2期311-313,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 乳腺肿瘤 微血管密度 抑血管内皮生长因子 免疫组织化学 病理因素 Breast carcinoma Microvessel density Vascular endothelial growth factor Immunohistochemistry
  • 相关文献

参考文献6

二级参考文献11

  • 1贾兰玲,李振,胡萍,董文瑞.血型抗原单克隆抗体对乳腺癌新生血管的检测及其意义[J].中国医科大学学报,1995,24(1):99-100. 被引量:3
  • 2[1]Keck PJ,Hauser SD,Krivi G,et al.Vascular permeability factor, an endothelial cell mitogen regulated to PDGF. Science 1989; 246:1309-12
  • 3[2]Arlet J.Nontraumatic avascular necrosis of the femoral head:Past,Present,and future.Clin Orthop 1992; 277:12-21
  • 4[3]Devine SM.Mesenchymal stem cells: will they have a role in the clinic? J cell Biochem Suppl 2002;38:73-9
  • 5[4]Ringe J, Kape C, Burmester GR, Sittinger M.Stem cells for regenerative medicine advances in the engineering of tissues and organs.Natr Wissenschaften 2002;89(8):338-51
  • 6[5]Noel D,Djouad F,Jorgense C.Regenerative medicine through mesenchymal stem cells for bone and cartilage repair.Curr Opin Ivestig Drug 2002;3(7):1000-4
  • 7[6]Ferrara N, Henezel WJ.Pituitary follicular cells secrete a novel heparinbinding growth factor.Biochem Biophys Res Commun 1989; 161:851-62
  • 8[7]Ogilvie C,Lee M,Miclau T,et al.The role of angiogenesis in bone regeneration: in proceedings of the 46th annual meeting orthopedic research society.Frorida:Orlando 2000: 12-6
  • 9[8]Hori Y,Nakamura T,Kimura D.Experimental study on tissue engineering of the small instestine by mesenchymal stem cells seeding.J Surg Res 2002;102(2):156-60
  • 10李宏江,朱精强.乳癌中微血管活性检测的意义[J].国外医学(外科学分册),1998,25(6):344-347. 被引量:11

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部